Insider Intelligence delivers leading-edge research to clients in a variety of forms, including full-length reports and data visualizations to equip you with actionable takeaways for better business decisions.
In-depth analysis, benchmarks and shorter spotlights on digital trends.
Learn More
Interactive projections with 10k+ metrics on market trends, & consumer behavior.
Learn More
Proprietary data and over 3,000 third-party sources about the most important topics.
Learn More
Industry KPIs
Industry benchmarks for the most important KPIs in digital marketing, advertising, retail and ecommerce.
Learn More
Client-only email newsletters with analysis and takeaways from the daily news.
Learn More
Analyst Access Program
Exclusive time with the thought leaders who craft our research.
Learn More

About Insider Intelligence

Our goal at Insider Intelligence is to unlock digital opportunities for our clients with the world’s most trusted forecasts, analysis, and benchmarks. Spanning five core coverage areas and dozens of industries, our research on digital transformation is exhaustive.
Our Story
Learn more about our mission and how Insider Intelligence came to be.
Learn More
Rigorous proprietary data vetting strips biases and produces superior insights.
Learn More
Our People
Take a look into our corporate culture and view our open roles.
Join the Team
Contact Us
Speak to a member of our team to learn more about Insider Intelligence.
Contact Us
See our latest press releases, news articles or download our press kit.
Learn More
Advertising & Sponsorship Opportunities
Reach an engaged audience of decision-makers.
Learn More
Browse our upcoming and past events, recent podcasts, and other featured resources.
Learn More
Tune in to eMarketer's daily, weekly, and monthly podcasts.
Learn More

Amwell partners with CVS, reports 10% subscription revenue increase for Q2

The news: During its Q2 2022 earnings call on August 4, Amwell said it will partner with CVS on the retailer’s new Virtual Primary Care service.

Alongside the news: Despite telehealth usage declining overall, Amwell reported a 7% annual increase in revenues, hitting $64.5 million for Q2 2022, up from $60.2 million in Q2 2021.

  • Amwell also achieved a 10% subscription revenue increase for Q2, up to $29.6 million from $26.8 million in Q2 2021.
  • Amwell says its total virtual care visits totaled more than 1.5 million in Q2 2022 compared with 1.3 million in Q2 2021.

How we got here: CVS announced in May that it will launch its virtual care platform next year. Aetna plan sponsors and clients of CVS pharmacy benefits manager Caremark will have access to the platform.

  • In April 2021, Amwell launched its Converge technology platform to enable care in person, remotely, and through automation.
  • CVS will open up its virtual solution to Aetna members in 2023.

Trendspotting: Despite the growth of partnerships with pharmacies, and the rising numbers from Amwell, telehealth use has been dropping overall this year.

  • US adults telehealth use (measured by medical claim lines) decreased 6.1% in March, according to nonprofit Fair Health.

What’s next? We’re watching the competition between two virtual care platforms: Amwell’s Converge and Teladoc’s Primary360.

For context, CVS is already working with Teladoc on a virtual care solution, offering it to self-funded employers. So, CVS now has deals with both companies.

Although Teladoc is expanding its Primary360 platform, it posted a steep loss of $3.1 billion in Q2. The race is on to see who will develop stronger relationships with pharma, and with the deep amount of integrations that Amwell Converge offers, Amwell should be well positioned for more pharma deals in primary care.

In the earnings call, Amwell CEO Ido Schoenberg hinted at more integrations to come as its platform will serve as a layer to connect patients, providers, payers, and employers.

Go deeper: Check out our US Telehealth Trends 2022 report.

This article originally appeared in Insider Intelligence's Digital Health Briefing—a daily recap of top stories reshaping the healthcare industry. Subscribe to have more hard-hitting takeaways delivered to your inbox daily.